Urination Disorders
Welcome,         Profile    Billing    Logout  
 38 Companies   62 Products   62 Products   62 Mechanisms of Action   5 Trials   685 News 


12345678910111213...1314»
  • ||||||||||  NN1213 / Novo Nordisk, Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
    Trial completion date, Trial termination, Trial primary completion date:  Thrombolysis in Ischemic Spinal Cord Stroke (clinicaltrials.gov) -  Apr 19, 2019   
    P2,  N=12, Terminated, 
    Phase classification: P4 --> P=N/A Trial completion date: Oct 2018 --> Mar 2019 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2018 --> Mar 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  CARESS: Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy (clinicaltrials.gov) -  Mar 15, 2019   
    P=N/A,  N=72, Completed, 
    Trial completion date: Oct 2018 --> Mar 2019 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2018 --> Mar 2019 Recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Phase classification, Trial completion date:  Muscle Progenitor Cell Therapy for Urinary Incontinence (clinicaltrials.gov) -  Jan 10, 2019   
    P1,  N=10, Completed, 
    Active, not recruiting --> Completed | Phase classification: PN/A --> P2 | N=25 --> 69 Active, not recruiting --> Completed | Phase classification: P1/2 --> P1 | Trial completion date: Jan 2019 --> Jan 2018
  • ||||||||||  losartan / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria (clinicaltrials.gov) -  Oct 10, 2018   
    P3,  N=58, Completed, 
    Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Sep 2016 | Trial primary completion date: Dec 2017 --> Jul 2016
  • ||||||||||  Rituxan (rituximab) / Roche
    Enrollment change:  Rituximab to Prevent Recurrence of Proteinuria (clinicaltrials.gov) -  Sep 20, 2018   
    P3,  N=30, Terminated, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Sep 2016 | Trial primary completion date: Dec 2017 --> Jul 2016 N=43 --> 30
  • ||||||||||  NN1213 / Novo Nordisk
    Phase classification, Trial completion date, Trial primary completion date:  Comparing Minisling to Tension Free Vaginal Tape in Mangement of Stress Urinary Incontinence (clinicaltrials.gov) -  Aug 14, 2018   
    P2/3,  N=48, Completed, 
    Recruiting --> Completed | N=50 --> 30 Phase classification: P4 --> P2/3 | Trial completion date: Jun 2016 --> Oct 2017 | Trial primary completion date: Jun 2016 --> Jun 2017
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Enrollment change:  Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis (clinicaltrials.gov) -  Aug 9, 2018   
    P=N/A,  N=6, Completed, 
    Phase classification: P4 --> P2/3 | Trial completion date: Jun 2016 --> Oct 2017 | Trial primary completion date: Jun 2016 --> Jun 2017 Recruiting --> Completed | N=15 --> 6
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Pelvic Floor Muscle Training(PFMT) on Lower Urinary Tract Symptoms (LUTS) in Men With Stroke (clinicaltrials.gov) -  Aug 1, 2018   
    P=N/A,  N=31, Completed, 
    Recruiting --> Completed | N=15 --> 6 Active, not recruiting --> Completed | N=120 --> 31 | Trial completion date: Dec 2015 --> Apr 2017 | Trial primary completion date: Dec 2013 --> Apr 2017
  • ||||||||||  Trial completion date, Trial primary completion date:  Does Bladder Instillation Reduce Time to Discharge After Sling Surgery (clinicaltrials.gov) -  Jul 18, 2018   
    P=N/A,  N=250, Recruiting, 
    Recruiting --> Completed Trial completion date: Dec 2016 --> Dec 2025 | Trial primary completion date: Dec 2015 --> Dec 2025
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Foot Neuromodulation for Nocturnal Enuresis (clinicaltrials.gov) -  Jun 12, 2018   
    P=N/A,  N=25, Completed, 
    Trial completion date: Dec 2016 --> Dec 2025 | Trial primary completion date: Dec 2015 --> Dec 2025 Enrolling by invitation --> Completed
  • ||||||||||  Trial completion, Phase classification, Trial completion date:  ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males (clinicaltrials.gov) -  Jun 3, 2018   
    P=N/A,  N=123, Completed, 
    Phase classification: P2 --> P2a Active, not recruiting --> Completed | Phase classification: P2/3 --> PN/A | Trial completion date: Dec 2016 --> Dec 2017
  • ||||||||||  Enrollment change:  Impact of Screening Patients With HIV for Kidney Disease (clinicaltrials.gov) -  Jun 2, 2018   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | Phase classification: P2/3 --> PN/A | Trial completion date: Dec 2016 --> Dec 2017 N=1400 --> 0
  • ||||||||||  Trial completion:  TVTOxTVTS: TVTO (clinicaltrials.gov) -  Jun 2, 2018   
    P4,  N=124, Completed, 
    N=1400 --> 0 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change:  LILA: Lessening Incontinence Through Low-impact Activity (clinicaltrials.gov) -  May 1, 2018   
    P=N/A,  N=56, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | N=80 --> 56
  • ||||||||||  Phase classification, Enrollment change, Trial primary completion date:  Focal Therapy for Prostate Cancer Using HIFU (clinicaltrials.gov) -  Apr 20, 2018   
    P=N/A,  N=354, Recruiting, 
    Active, not recruiting --> Completed | N=80 --> 56 Phase classification: P2 --> P=N/A | N=272 --> 354 | Trial primary completion date: Jun 2014 --> Dec 2028
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis (clinicaltrials.gov) -  Apr 11, 2018   
    P4,  N=0, Withdrawn, 
    Phase classification: P2 --> P=N/A | N=272 --> 354 | Trial primary completion date: Jun 2014 --> Dec 2028 N=110 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2018 --> Jul 2020
  • ||||||||||  Phase classification, Enrollment change:  Evaluation of Albuminuria HIV-Infected Patients (clinicaltrials.gov) -  Apr 6, 2018   
    P,  N=252, Completed, 
    N=110 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2018 --> Jul 2020 Phase classification: P=N/A --> P | N=134 --> 252
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Vitamin D Supplementation in Older Adults With Urinary Incontinence (clinicaltrials.gov) -  Mar 9, 2018   
    P=N/A,  N=243, Completed, 
    Active, not recruiting --> Completed | Phase classification: PN/A --> P Recruiting --> Completed | N=69 --> 243 | Trial primary completion date: Jan 2018 --> Aug 2017
  • ||||||||||  prazosin / Generic mfg.
    Trial completion, Trial completion date, Trial initiation date, Trial primary completion date, Surgery:  Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery (clinicaltrials.gov) -  Feb 8, 2018   
    P=N/A,  N=142, Completed, 
    Recruiting --> Completed | N=69 --> 243 | Trial primary completion date: Jan 2018 --> Aug 2017 Recruiting --> Completed | Trial completion date: Dec 2017 --> Nov 2017 | Initiation date: Nov 2012 --> Nov 2012 | Trial primary completion date: Dec 2017 --> Nov 2017
  • ||||||||||  Phase classification:  Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence (clinicaltrials.gov) -  Feb 5, 2018   
    P=N/A,  N=50, Completed, 
    Recruiting --> Completed | Trial completion date: Dec 2017 --> Nov 2017 | Initiation date: Nov 2012 --> Nov 2012 | Trial primary completion date: Dec 2017 --> Nov 2017 Phase classification: P2 --> P=N/A
  • ||||||||||  Trial primary completion date, HEOR:  InterStim Prospective Database (clinicaltrials.gov) -  Dec 26, 2017   
    P=N/A,  N=736, Terminated, 
    Recruiting --> Completed | Trial primary completion date: Mar 2017 --> Aug 2017 Trial primary completion date: Apr 2029 --> Dec 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka (clinicaltrials.gov) -  Nov 1, 2017   
    P=N/A,  N=200, Completed, 
    Recruiting --> Completed | Phase classification: P1 --> PN/A | N=400 --> 176 | Trial primary completion date: Mar 2017 --> Nov 2017 Not yet recruiting --> Completed | N=350 --> 200 | Trial primary completion date: Nov 2014 --> May 2017
  • ||||||||||  Vesicare (solifenacin) / Astellas
    Enrollment change, Trial termination, Trial primary completion date:  BryoSoliP: Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder (clinicaltrials.gov) -  Oct 26, 2017   
    P3,  N=9, Terminated, 
    Not yet recruiting --> Completed | N=350 --> 200 | Trial primary completion date: Nov 2014 --> May 2017 N=30 --> 9 | Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Apr 2016
  • ||||||||||  Trial completion, Surgery, Metastases:  Advanced Pelvic Floor Training Program for Prostate Cancer Surgery (clinicaltrials.gov) -  Oct 26, 2017   
    P1/2,  N=88, Completed, 
    N=30 --> 9 | Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Apr 2016 Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Combined Spinal Epidural Urinary Retention (clinicaltrials.gov) -  Oct 10, 2017   
    P=N/A,  N=56, Terminated, 
    Active, not recruiting --> Completed N=200 --> 56 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Dec 2016; Change in procedure.US technically challenging.
  • ||||||||||  Trial completion, Phase classification, Enrollment change:  Changes in ALPP in Women With SUI Following Air Instillation (clinicaltrials.gov) -  Oct 6, 2017   
    P=N/A,  N=8, Completed, 
    N=200 --> 56 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Dec 2016; Change in procedure.US technically challenging. Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=10 --> 8
  • ||||||||||  Phase classification, Trial initiation date:  Incontinence Ring on Stress Urinary Incontinence (clinicaltrials.gov) -  Sep 27, 2017   
    P=N/A,  N=29, Terminated, 
    Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=10 --> 8 Phase classification: P4 --> P=N/A | Initiation date: Jan 2007 --> Jun 2006
  • ||||||||||  Enrollment closed, Trial primary completion date, Surgery, Metastases:  Advanced Pelvic Floor Training Program for Prostate Cancer Surgery (clinicaltrials.gov) -  Aug 23, 2017   
    P1/2,  N=88, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Sep 2017
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Trial termination:  Rituximab to Prevent Recurrence of Proteinuria (clinicaltrials.gov) -  Aug 22, 2017   
    P3,  N=43, Terminated, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Sep 2017 Completed --> Terminated; Voluntarily terminated by PI due to lack of feasibility.